These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 10022683

  • 1. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells.
    Höltl L, Rieser C, Papesh C, Ramoner R, Herold M, Klocker H, Radmayr C, Stenzl A, Bartsch G, Thurnher M.
    J Urol; 1999 Mar; 161(3):777-82. PubMed ID: 10022683
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H, Zhou FJ, Wang QJ, Qin ZK, Huang LX, Liu ZW, Han H, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
    [Abstract] [Full Text] [Related]

  • 3. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P, Tso CL, Gitlitz B, Kaboo R, Hinkel A, Frand S, Kiertscher S, Roth MD, deKernion J, Figlin R, Belldegrun A.
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [Abstract] [Full Text] [Related]

  • 4. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.
    Cancer Res; 2001 Nov 01; 61(21):7925-33. PubMed ID: 11691814
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.
    Höltl L, Zelle-Rieser C, Gander H, Papesh C, Ramoner R, Bartsch G, Rogatsch H, Barsoum AL, Coggin JH, Thurnher M.
    Clin Cancer Res; 2002 Nov 01; 8(11):3369-76. PubMed ID: 12429623
    [Abstract] [Full Text] [Related]

  • 6. Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate.
    Soleimani A, Berntsen A, Svane IM, Pedersen AE.
    Scand J Immunol; 2009 Nov 01; 70(5):481-9. PubMed ID: 19874553
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cell-based immunotherapy of renal cell carcinoma.
    Thurnher M, Rieser C, Höltl L, Papesh C, Ramoner R, Bartsch G.
    Urol Int; 1998 Nov 01; 61(2):67-71. PubMed ID: 10049189
    [Abstract] [Full Text] [Related]

  • 8. Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.
    Hegmans JP, Veltman JD, Lambers ME, de Vries IJ, Figdor CG, Hendriks RW, Hoogsteden HC, Lambrecht BN, Aerts JG.
    Am J Respir Crit Care Med; 2010 Jun 15; 181(12):1383-90. PubMed ID: 20167848
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells.
    Matsumoto A, Haraguchi K, Takahashi T, Azuma T, Kanda Y, Tomita K, Kurokawa M, Ogawa S, Takahashi K, Chiba S, Kitamura T.
    Int J Urol; 2007 Apr 15; 14(4):277-83. PubMed ID: 17470153
    [Abstract] [Full Text] [Related]

  • 10. Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma.
    Kim JH, Lee Y, Bae YS, Kim WS, Kim K, Im HY, Kang WK, Park K, Choi HY, Lee HM, Baek SY, Lee H, Doh H, Kim BM, Kim CY, Jeon C, Jung CW.
    Clin Immunol; 2007 Dec 15; 125(3):257-67. PubMed ID: 17916447
    [Abstract] [Full Text] [Related]

  • 11. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
    Chang GC, Lan HC, Juang SH, Wu YC, Lee HC, Hung YM, Yang HY, Whang-Peng J, Liu KJ.
    Cancer; 2005 Feb 15; 103(4):763-71. PubMed ID: 15637694
    [Abstract] [Full Text] [Related]

  • 12. Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma.
    Rieser C, Ramoner R, Höltl L, Rogatsch H, Papesh C, Stenzl A, Bartsch G, Thurnher M.
    Urol Int; 1999 Feb 15; 63(3):151-9. PubMed ID: 10738185
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J.
    J Immunother; 2006 Feb 15; 29(5):545-57. PubMed ID: 16971810
    [Abstract] [Full Text] [Related]

  • 14. [Immune anticancer response: recent advances in the treatment of renal cell carcinoma].
    Bouet F, Catros V.
    Ann Biol Clin (Paris); 2004 Feb 15; 62(3):257-68. PubMed ID: 15217758
    [Abstract] [Full Text] [Related]

  • 15. Dendritic cell-tumor fusion vaccines for renal cell carcinoma.
    Avigan D.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 2):6347S-52S. PubMed ID: 15448029
    [Abstract] [Full Text] [Related]

  • 16. Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma.
    Sievers E, Albers P, Schmidt-Wolf IG, Märten A.
    J Urol; 2004 Jan 15; 171(1):114-9. PubMed ID: 14665857
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides.
    Chagnon F, Tanguay S, Ozdal OL, Guan M, Ozen ZZ, Ripeau JS, Chevrette M, Elhilali MM, Thompson-Snipes LA.
    Clin Cancer Res; 2005 Feb 01; 11(3):1302-11. PubMed ID: 15709202
    [Abstract] [Full Text] [Related]

  • 18. Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.
    Oosterwijk-Wakka JC, Tiemessen DM, Bleumer I, de Vries IJ, Jongmans W, Adema GJ, Debruyne FM, de Mulder PH, Oosterwijk E, Mulders PF.
    J Immunother; 2002 Feb 01; 25(6):500-8. PubMed ID: 12439347
    [Abstract] [Full Text] [Related]

  • 19. Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study.
    Wei YC, Sticca RP, Li J, Holmes LM, Burgin KE, Jakubchak S, Bouton-Verville H, Williamson J, Meyer K, Evans L, Martin J, Stephenson JJ, Trocha S, Smith S, Wagner TE.
    Oncol Rep; 2007 Sep 01; 18(3):665-71. PubMed ID: 17671717
    [Abstract] [Full Text] [Related]

  • 20. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
    Lesimple T, Neidhard EM, Vignard V, Lefeuvre C, Adamski H, Labarrière N, Carsin A, Monnier D, Collet B, Clapisson G, Birebent B, Philip I, Toujas L, Chokri M, Quillien V.
    Clin Cancer Res; 2006 Dec 15; 12(24):7380-8. PubMed ID: 17189411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.